| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eccd894c99fea2d1c0c8735872bb2309 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-26 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H23-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1996-11-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a2b2f39d889002473da193a526b5ae1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a47b6054afb4c848e11b1f646c0951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b90b5c5c1cc5aa337593401432dac591
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85c97bb6951b761379e907f9383ecf31 |
| publicationDate |
1998-11-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-5834448-A |
| titleOfInvention |
Dosage form of hydroxocobalamin and its use in cyanide poisoning |
| abstract |
The invention relates to a new dosage form of hydroxocobalamin which serves in the treatment of cyanide poisoning and contains hydroxocobalamin in freeze-dried form. The hydroxocobalamin is freeze-dried in an acidic medium so as to be practically instantly redissolved in a neutral saline solution. The present invention also relates to a process for producing hydroxocobalamin-based pharmaceutical compositions as well as to first aid kits containing these compositions and methods of using such kits for the treatment of cyanide poisoning. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9585908-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6187761-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-4173618-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-100376251-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6147084-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757354-B2 |
| priorityDate |
1995-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |